A-CURE FACULTY

George W. Vetrovec, MD

Certifications

Emeritus Professor of Medicine

University / Hospital Affiliation

VCU Pauley Heart Center; Virginia Commonwealth University

Additional Titles and Roles

Executive Chairperson of ACURE

Focus Areas

Interventional Cardiology, Clinical Research

About

Dr. George W. Vetrovec, MACC and MSCAI is an Emeritus Professor of Medicine at VCU Pauley Heart Center at VCU in Richmond, Virginia. His experience covers four decades of interventional cardiology and his research has focused on optimal management of ischemic heart disease particularly involving high risk PCI, most often with reduced Left Ventricular function. He has extensive experience in new cardiovascular device innovation and evaluation. During his career, He has served on the Boards of the AHA, ACC and SCAI, including SCAI President. Dr. Vetrovec remains actively in interventional cardiology, as a consultant, teacher as well as serving on multiple editorial boards and is the Editorial Lead for the Angiography and Interventional Section of ACC.org.

Manuscripts & Publications

Patterns Of Care And Outcomes Of Ambulatory Endovascular Interventions In Lower Extremity Peripheral Arterial Disease

Cardiology, Cardiovascular Surgery
Lower extremity endovascular intervention (LE-EVI) is gaining popularity as the primary treatment modality for patients with symptomatic peripheral artery disease refractory to noninvasive management.

Best Practices For Cardiac Catheterization Laboratory Morbidity And Mortality Conferences

Cardiology, Cardiovascular Surgery
Cardiac catheterization laboratory (CCL) morbidity and mortality conferences (MMCs) are a critical component of CCL quality improvement programs and are important for the education of cardiology trainees and the lifelong learning of CCL physicians and team members.

Strategies For Reducing Vascular And Bleeding Risk For Percutaneous Left Ventricular Assist Device-Supported High-Risk Percutaneous Coronary Intervention

Cardiology, Cardiovascular Surgery
In patients at high risk for haemodynamic instability during percutaneous coronary intervention (PCI), practitioners are increasingly opting for prophylactic mechanical circulatory support, such as the Impella® heart pump (Abiomed, Danvers, MA, USA).